Array BioPharma Inc (ARRY)

Add to Watchlists
Create an Alert
14.21 +0.48  +3.50% NASDAQ Aug 16, 20:00 Delayed 2m USD

Array BioPharma Inc Total Liabilities (Quarterly):

240.62M for June 30, 2018
View 4,000+ financial data types
Browse...
View Full Chart

Array BioPharma Inc Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Array BioPharma Inc Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2018 240.62M
March 31, 2018 231.86M
Dec. 31, 2017 220.66M
Sept. 30, 2017 275.69M
June 30, 2017 267.42M
March 31, 2017 228.49M
Dec. 31, 2016 220.15M
Sept. 30, 2016 218.98M
June 30, 2016 206.83M
March 31, 2016 210.99M
Dec. 31, 2015 194.04M
Sept. 30, 2015 162.65M
June 30, 2015 155.55M
March 31, 2015 158.29M
Dec. 31, 2014 177.58M
Sept. 30, 2014 172.91M
June 30, 2014 162.35M
March 31, 2014 158.49M
Dec. 31, 2013 151.67M
Sept. 30, 2013 165.81M
June 30, 2013 157.90M
March 31, 2013 159.85M
Dec. 31, 2012 160.09M
Sept. 30, 2012 181.91M
June 30, 2012 193.88M
   
March 31, 2012 198.81M
Dec. 31, 2011 209.34M
Sept. 30, 2011 233.61M
June 30, 2011 220.23M
March 31, 2011 257.86M
Dec. 31, 2010 258.16M
Sept. 30, 2010 264.49M
June 30, 2010 275.86M
March 31, 2010 240.97M
Dec. 31, 2009 244.62M
Sept. 30, 2009 192.64M
June 30, 2009 168.76M
March 31, 2009 163.45M
Dec. 31, 2008 163.45M
Sept. 30, 2008 129.32M
June 30, 2008 125.05M
March 31, 2008 107.17M
Dec. 31, 2007 104.99M
Sept. 30, 2007 111.79M
June 30, 2007 67.27M
March 31, 2007 70.12M
Dec. 31, 2006 64.33M
Sept. 30, 2006 64.22M
June 30, 2006 33.53M
March 31, 2006 29.21M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Advertisement

ARRY Total Liabilities (Quarterly) Benchmarks

Benchmarks
Intra-Cellular Therapies Inc 21.69M
Ionis Pharmaceuticals Inc 1.430B
Puma Biotechnology Inc 189.32M

ARRY Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 151.67M Dec 2013
Maximum 275.69M Sep 2017
Average 199.05M

ARRY Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("ARRY", "liabilities")
  • Last 5 data points: =YCS("ARRY", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.